Literature DB >> 1649376

Polyclonal and monoclonal antibodies against human tissue inhibitor of metalloproteinases (TIMP) and the design of an enzyme-linked immunosorbent assay to measure TIMP.

I M Clark1, L K Powell, J K Wright, T E Cawston.   

Abstract

Both polyclonal and monoclonal antibodies have been raised against purified human fibroblast tissue inhibitor of metalloproteinases (TIMP) and characterised. Combinations of antibodies were tested for their suitability in a double antibody sandwich ELISA to measure TIMP. Two combinations were applicable to the immunoassay: (i) a monoclonal capture antibody with a polyclonal detecting antibody; (ii) two monoclonal antibodies. The assay range was (i) 2-50 ng/ml and (ii) 5-50 ng/ml of human TIMP. The levels of TIMP in several human body fluids were measured using assay (ii), and values in ng/ml with standard deviations (n-1) obtained as follows: serum, 299 +/- 62; plasma, 109 +/- 35; amniotic fluid, 724 +/- 62; cerebrospinal fluid, 144 +/- 156; saliva, 209 +/- 103.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649376     DOI: 10.1016/s0934-8832(11)80211-8

Source DB:  PubMed          Journal:  Matrix        ISSN: 0934-8832


  4 in total

1.  Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor alpha by the release of collagen fragments via collagenases.

Authors:  T G Morgan; A D Rowan; S C Dickinson; D Jones; A P Hollander; D Deehan; T E Cawston
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

2.  Human shoulder tendon biopsy samples in organ culture produce procollagenase and tissue inhibitor of metalloproteinases.

Authors:  S Dalton; T E Cawston; G P Riley; I J Bayley; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

3.  Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.

Authors:  Giuseppe Derosa; Angela D'Angelo; Filippo Scalise; Maria A Avanzini; Carmine Tinelli; Emmanouil Peros; Elena Fogari; Arrigo F G Cicero
Journal:  Heart Vessels       Date:  2007-11-26       Impact factor: 2.037

4.  Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer.

Authors:  M N Holten-Andersen; G Murphy; H J Nielsen; A N Pedersen; I J Christensen; G Høyer-Hansen; N Brünner; R W Stephens
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.